Authors
Saeideh Jafarinejad-Farsangi, Ali Farazmand, Mahdi Mahmoudi, Farhad Gharibdoost, Elham Karimizadeh, Farshid Noorbakhsh, Habibeh Faridani, Ahmad Reza Jamshidi
Publication date
2015/8/18
Journal
Autoimmunity
Volume
48
Issue
6
Pages
369-378
Publisher
Informa Healthcare
Description
The most prominent feature of systemic sclerosis (SSc) and other diseases associated with fibrosis is the prolonged activation of fibroblasts not eliminated by apoptosis, hence characterized by accumulation of more extra cellular matrix (ECM). We tend to verify if microRNA-29a (miR-29a) as an anti-fibrotic factor could induce apoptosis in SSc fibroblasts. We did not detect apoptosis in SSc fibroblasts. We found that Bcl-2 expression was upregulated in SSc fibroblasts and the ratio of Bax:Bcl-2 in these cells was significantly lower (p = 0.02) compared to normal fibroblasts. Transfection of both SSc and transforming growth factor-β (TGF-β) stimulated fibroblasts by miR-29a mimic, significantly decreased the expression of two anti-apoptotic members of the Bcl-2 family, Bcl-2 (p = 0.0005, p = 0.01) and Bcl-XL (p = 0.0001, p = 0.006), resulted in enhanced Bax:Bcl-2 ratio and induced a high rate of apoptosis …
Total citations
2015201620172018201920202021202220232024210131018810751